VaccinesNews.net

Vaccines Xagena

Search results for "9-valent HPV Vaccine"

Merck & Co has announced that in the pivotal phase III efficacy study, its investigational 9-valent HPV vaccine ( V503 ) prevented approximately 97% of cervical, vaginal and vulvar pre-cancers cau ...